Drug intelligence / Profile preview

walnut oil

Development stage
Unknown
Lead developer
Shiraz University of Medical Sciences
Administration
Oral
01

Overview

Walnut oil is a natural botanical oil extracted from the seeds of the English walnut (*Juglans regia*). It is highly enriched in polyunsaturated fatty acids (PUFAs), particularly linoleic acid and alpha-linolenic acid (ALA), an omega-3 fatty acid. Walnut oil is primarily utilized as a dietary supplement and nutraceutical for its antioxidant, anti-inflammatory, and lipid-lowering properties. Clinical studies have demonstrated its efficacy in improving lipid profiles in patients with hyperlipidemia and type 2 diabetes, significantly reducing total cholesterol, low-density lipoprotein (LDL), and triglycerides. In preclinical research, walnut oil has also shown potential cardioprotective effects, such as mitigating letrozole-induced cardiotoxicity in zebrafish models by preventing the downregulation of G-protein coupled estrogen receptor 1 (GPER1) and modulating nitric oxide synthase 1 (NOS1) expression.

Other names
Juglans regia seed oilPersian walnut oil
02

Targets

ASIC (ASIC family)FXR (Farnesoid x-activated receptor)GPER1 (G protein-coupled estrogen receptor 1)NR1H3 (Liver X receptor beta)NOS1 (nNOS)PXR (Pregnane X receptor)SCD1 (Stearoyl-CoA desaturase 1)

Beyond the preview

Go deeper on walnut oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on walnut oil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call